RUA Life Sciences plc
LSE: RUA.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- William Donald Brown
- Employees
- 40
- Headquarters
- Irvine, United Kingdom
- IPO year
- 1997
- Market cap
- £14.9M
- Website
- https://rualifesciences.com
Loading RUA…
Loading profile data…Frequently asked questions about RUA
What does RUA Life Sciences plc (RUA.L) do?
RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiolog...
Where does RUA.L trade?
RUA Life Sciences plc (RUA.L) trades on the London Stock Exchange.
What sector is RUA.L in?
RUA Life Sciences plc (RUA.L) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of RUA Life Sciences plc?
William Donald Brown is the chief executive officer of RUA Life Sciences plc (RUA.L).
Where is RUA Life Sciences plc headquartered?
RUA Life Sciences plc is headquartered in United Kingdom.
Does RUA.L pay a dividend?
RUA Life Sciences plc (RUA.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RUA.L go public?
RUA Life Sciences plc (RUA.L) completed its initial public offering in 1997.